Status
Conditions
Treatments
About
This study is to evaluate the incidence of interstitial pneumonia in lymphoma patients treated with liposomal doxorubucin. The treatment response and other adverse events will also be studied.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
2,000 participants in 1 patient group
Loading...
Central trial contact
WL Z
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal